Return to List
Results 61–80 of 94
Title Date
61.

Personalized Genomic Testing for Disease Risk

Number 527

(Reaffirmed 2014)

ABSTRACT: Advances in genetic technologies have led to the identification of hundreds of single nucleotide polymorphisms that are associated with a variety of complex diseases, including cancer, diab...

June 2012

PDF Format
62.

Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism

Number 556

ABSTRACT: The development of menopausal symptoms and related disorders, which lead women to seek prescriptions for postmenopausal estrogen therapy and hormone therapy, is a common reason for a patien...

April 2013

PDF Format
63.

Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus

Number 595

Abstract: Preexposure prophylaxis is defined as the administration of antiretroviral medications to individuals who are not infected with human immunodeficiency virus (HIV) and are at the highest ris...

May 2014

PDF Format
64.

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

ABSTRACT: Preimplantation genetic screening differs from preimplantation genetic diagnosis for single gene disorders and was introduced for the detection of chromosomal aneuploidy. Current data does ...

March 2009

PDF Format
65.

Preparing for Clinical Emergencies in Obstetrics and Gynecology

Number 590

(Replaces Committee Opinion Number 487, April 2011)

ABSTRACT: Patient care emergencies may occur at any time in any setting, particularly the inpatient setting. It is important that obstetrician–gynecologists prepare themselves by assessing potential ...

March 2014

PDF Format
66.

Primary Ovarian Insufficiency in Adolescents and Young Women

Number 605

ABSTRACT: Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years. There is no consensus on criteria to identify primary ovaria...

July 2014

PDF Format
67.

Professional Liability and Gynecology-Only Practice

Number 567

(Replaces No. 408, June 2008)

ABSTRACT: Fellows of the American College of Obstetricians and Gynecologists may choose to limit the scope of their practices to gynecology and, accordingly, may choose not to carry professional liab...

July 2013

PDF Format
68.

Reprocessed Single-Use Devices

Number 537

ABSTRACT: The reprocessing and reuse of single-use instruments has become increasingly common. Although there are limited data on reprocessed single-use devices, existing studies have found a signifi...

October 2012

PDF Format
69.

Reproductive and Sexual Coercion

Number 554

ABSTRACT: Reproductive and sexual coercion involves behavior intended to maintain power and control in a relationship related to reproductive health by someone who is, was, or wishes to be involved i...

February 2013

PDF Format
70.

Reproductive Health Care for Adolescents with Human Immunodeficiency Virus

Number 572

ABSTRACT: Adolescents make up an increasing percentage of the U.S. population with human immunodeficiency virus (HIV). Adolescent-focused care is critical to identify and reduce at-risk behavior, com...

September 2013

PDF Format
71.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Number 535

ABSTRACT: Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the U.S. correctional system. In...

August 2012

PDF Format
72.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Number 540

ABSTRACT: Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones, and some data have suggested tha...

November 2012

PDF Format
73.

Sexual Assault

Number 592

(Replaces Committee Opinion Number 499, August 2011)

ABSTRACT: Reproductive-aged victims of sexual assault are at risk of unintended pregnancy, sexually transmitted infections, and mental health conditions, including posttraumatic stress disorder. Heal...

April 2014

PDF Format
74.

Solutions for Surgical Preparation of the Vagina

Number 571

ABSTRACT: Currently, only povidone-iodine preparations are approved for vaginal surgical-site antisepsis. However, there are compelling reasons to consider chlorhexidine gluconate solutions for off-l...

September 2013

PDF Format
75.

Statement on Surgical Assistants

Number 240

(Reaffirmed 2013, Replaces No. 145, November 1994)

Competent surgical assistants should be available for all major obstetric and gynecologic operations. In many cases, the complexity of the surgery or the patient's condition will require the assistan...

August 2000

PDF Format
76.

Sterilization of Women Including Those With Mental Disabilities

Number 371

(Reaffirmed 2009)

ABSTRACT: Sterilization, like any other surgical procedure, must be carried out under the general ethical principles of respect for autonomy, beneficence, and justice. Women requesting sterilization ...

July 2007

PDF Format
77.

Supracervical Hysterectomy

Number 388

(Reaffirmed 2013)

ABSTRACT: Women with known or suspected gynecologic cancer, current or recent cervical dysplasia, or endometrial hyperplasia are not candidates for a supracervical procedure. Patients electing suprac...

November 2007

PDF Format
78.

Surrogate Motherhood

Number 397

ABSTRACT: Ethical responsibilities are described for obstetrician–gynecologists who choose to participate in surrogacy arrangements by 1) advising couples who are considering surrogacy, 2) counseling...

February 2008

PDF Format
79.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT: Tamoxifen, a nonsteroidal antiestrogen agent, is widely used as adjunctive therapy for women with breast cancer, and it has been approved by the U.S. Food and Drug Administration for adjuva...

June 2014

PDF Format
80.

The Initial Reproductive Health Visit

Number 598

(Replaces Committee Opinion Number 460, July 2010)

Abstract: The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years. The initial repro...

May 2014

PDF Format